Abstract: Antibiotic rapamycin is producible by culturing Streptomyces hygroscopicus NRRL 5491 in an aqueous nutrient medium. Rapamycin has antifungal properties. Methods for its preparation and use are disclosed.
Type:
Grant
Filed:
September 25, 1975
Date of Patent:
November 23, 1976
Assignee:
Ayerst McKenna and Harrison Ltd.
Inventors:
Surendra N. Sehgal, Teodora M. Blazekovic, Claude Vezina
Abstract: New antibiotic substances are obtained by culturing a strain belonging to the genus Streptomyces and recovering said substances from the culture material. The new antibiotic substances possess insecticidal and acaracidal properties.
Abstract: Dihydro-A204, prepared by reduction of antibiotic A204I, and the physiologically-acceptable cationic salts thereof increase feed-utilization efficiency in ruminants and are anticoccidial agents.
Abstract: This invention relates to a new compound NA-337 and a process for producing the same by fermentation. NA-337 is positive in Dragendorff's reagent. NA-337 is confirmed to be a new compound having a fat-clearing activity. This compound is produced by fermentation, in which an NA-337-producing strain is cultured aerobically in a medium and the accumulated NA-337 is recovered from the cultured matters.
Abstract: This invention relates to new antibiotic substances B-41, a process for producing the antibiotic substance B-41 by culturing in a medium a B-41 producing strain belonging to the genus Streptomyces and then recovering the resulting B-41 from the cultured substance, and an insecticidal and acaricidal composition containing novel antibiotic substances B-41 as an active ingredient.
Abstract: The present invention provides a water-soluble pharmaceutical composition, comprising partricin and/or partricin methyl ester in admixture with at least one anionic and/or cationic surfactant.
Abstract: An antibiotic produced by Fusarium equiseti NRRL 5537 and given the trivial name equisetin is active against several genera of gram-positive bacteria.
Type:
Grant
Filed:
May 6, 1974
Date of Patent:
May 25, 1976
Assignee:
The United States of America as represented by the Secretary of Agriculture
Abstract: A process for producing the antibiotic pleuromutilin by cultivating strains of Clitopilus passeckerianus (Pil.) Sing in an aqueous nutrient medium. The production of esters of pleuromutilin and hydrogenation products thereof are also described. The pleuromutilin and derivatives thereof are useful as an antibacterial ingredient in animal feed compositions.
Type:
Grant
Filed:
August 14, 1967
Date of Patent:
April 6, 1976
Assignee:
Biochemie Ges.m.b.H.
Inventors:
Ernst Brandl, Franz Knauseder, Franz Rembold
Abstract: The present invention relates to triols derived from antibiotic substance, designated acid S, produced by Polyangium cellulosum var. fulvum (ATCC No. 25532), to the acetates thereof and to processes for the production of the triols and corresponding acetates. These triols and acetates are potent antifungal agents inhibiting the growth of a variety of fungi, including H. capsulatum, T. mentagrophytes and M. fulvum.
Type:
Grant
Filed:
June 24, 1974
Date of Patent:
January 13, 1976
Assignees:
Max VON Strandtmann, Warner-Lambert Company
Abstract: The present invention relates to keto and ketoxime derivatives of the novel antibiotic substance, acid S, produced by the microorganism Polyangium cellulosum var. fulvum (ATCC N0. 25532) and to processes for their preparation. The novel keto and ketoxime derivatives of acid S of this invention are useful antifungal agents.
Type:
Grant
Filed:
June 24, 1974
Date of Patent:
January 13, 1976
Assignee:
Warner-Lambert Company
Inventors:
David T. Connor, Samuel M. Ringel, Maximilian VON Strandtmann
Abstract: A new antibiotic, designated as antibiotic X-5108, is produced by a new species of streptomyces. The new antibiotic is active against gram-positive and gram-negative bacteria and produces growth stimulation and increased feed efficiency in poultry.